Evaxion Biotech Announces Closing of $27.6 Million Follow-on Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

COPENHAGEN, Denmark, Nov. 09, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer, bacterial diseases and viral infections, announced today the closing of its follow-on public offering […] Lire la suite »

Rackspace Technology hilft Awaze bei der Erzielung von Rekordleistung mit AWS-Projekt

LONDON, Nov. 09, 2021 (GLOBE NEWSWIRE) — Europas führende Gruppe für verwaltete Ferienimmobilienvermietung, Awaze, sagt, dass die Unterstützung des Unternehmens durch Rackspace Technology™ (NASDAQ: RXT), einem Unternehmen für End-to-End-Multicloud-Technologiedienste, bereits Dividenden auszahlt, da die Gruppe ein Rekordjahr feiert und einem weiteren Wachstum entgegensieht. Der Riese im Bereich der Selbstversorgung, der mehr […] Lire la suite »

Plug Power Announces 2021 Third Quarter Results

LATHAM, N.Y., Nov. 09, 2021 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen economy, has announced today its 2021 third quarter results. The quarterly shareholder letter has been posted at https://www.ir.plugpower.com/Q321Plug. A conference call will be held today, November […] Lire la suite »

Xen by Neuvana : le dispositif de stimulation du nerf vague unique en son genre désormais disponible au Royaume-Uni et dans l’Union européenne

WEST PALM BEACH, Floride, 09 nov. 2021 (GLOBE NEWSWIRE) — Neuvana LLC, société basée aux États-Unis, spécialisée dans le bien-être et leader en technologies des neurosciences, annonce la sortie très attendue de son nouveau produit, Xen, désormais disponible pour les consommateurs dans les 27 pays de l’Union européenne et au Royaume-Uni. […] Lire la suite »

Xen von Neuvana: Erstes Vagusnervstimulationsgerät seiner Art wird jetzt in das Vereinigte Königreich und die Europäische Union geliefert

WEST PALM BEACH, Florida, Nov. 09, 2021 (GLOBE NEWSWIRE) — Neuvana LLC mit Sitz in den USA, ein Wellness-Unternehmen, das führend im Bereich der neurowissenschaftlichen Technologie ist, gibt die mit Spannung erwartete Veröffentlichung von Xen bekannt, seines neuen Produkts, das Verbrauchern nun in den 27 Ländern der Europäischen Union und […] Lire la suite »

Digital revolution will innovate the entire hotel industry

DUBAI, United Arab Emirates, Nov. 09, 2021 (GLOBE NEWSWIRE) — Barrows, the provider of hotel investment and advisory services for hotels in the Middle East and Africa, is preparing for a new digital revolution in making the hotel industry smarter. Anyone who thinks we are already there with digitization in […] Lire la suite »

Sannam S4 Names Haike Manning as Executive Director, Southeast Asia, Acquiring LightPath Consulting’s International Education Services Business In Further Southeast Asia Expansion

HO CHI MINH CITY, Vietnam, Nov. 09, 2021 (GLOBE NEWSWIRE) — Sannam S4, a leading international education services provider, today announced the appointment of the former New Zealand Ambassador Mr. Haike Manning as Executive Director, South East Asia and through the acquisition of the education business of LightPath Consulting Group, […] Lire la suite »

Vision Hydrogen Acquires Hydrogen Producer VoltH2

JERSEY CITY, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Vision Hydrogen Corporation (OTCQB:VIHD) (the “Company”) announces the completion of the acquisition of VoltH2 Holdings AG (“VoltH2”), one of Western Europe’s leading developers of hydrogen production facilities and infrastructure. VoltH2 Founded in June 2020, VoltH2 is a European-based developer of […] Lire la suite »

COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021

Highlights: Positive topline results from phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression; rapid and sustained response for patients receiving a single 25mg dose of COMP360 psilocybin with psychological support Launch of phase II study of COMP360 psilocybin therapy for PTSD Positive signals from Maryland Oncology Hematology open-label investigator initiated study […] Lire la suite »